LINE-1 in cancer: Multifaceted functions and potential clinical implications

Genetics in Medicine

Volumn 18, Issue 5, 2016, Pages 431-439

  Xiao Jie, Lu ^a   Hui Ying, Xue ^b   Qi, Xiaolong ^a,c   Jiang, Xu ^d   Shi Jie, Ma ^e  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Huai'an Maternal and Child Health Care Center   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d XUZHOU MEDICAL UNIVERSITY   (China)

^e NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LONG INTERSPERSED NUCLEAR ELEMENT 1; TRANSCRIPTASE; TUMOR MARKER; UNCLASSIFIED DRUG; PROTEIN; RETROPOSON; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; CANCER CELL; CANCER GENETICS; CARCINOGENESIS; CHROMOSOME REARRANGEMENT; EPIGENETIC REPRESSION; GENE INACTIVATION; GENE STRUCTURE; GENOMIC INSTABILITY; HUMAN; HUMAN GENOME; MUTAGENESIS; PSEUDOGENE; RETROPOSON; REVIEW; GENETIC EPIGENESIS; GENETICS; LONG INTERSPERSED REPEAT; NEOPLASM; PATHOLOGY; PROMOTER REGION;

EPIGENESIS, GENETIC; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTEINS; RETROELEMENTS; RNA, SMALL INTERFERING;

EID: 84964831560     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2015.119     Document Type: Review

References (89)

1. Lander ES, Linton LM, Birren B, et al.; International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
2. Brouha B, Schustak J, Badge RM, et al. Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci USA 2003;100:5280-5285.
3. Miki Y, Nishisho I, Horii A, et al. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res 1992;52:643-645.
4. Kaer K, Speek M. Retroelements in human disease. Gene 2013;518:231-241.
5. Chen JM, Stenson PD, Cooper DN, Férec C. A systematic analysis of LINE-1 endonuclease-dependent retrotranspositional events causing human genetic disease. Hum Genet 2005;117:411-427.
6. Dombroski BA, Mathias SL, Nanthakumar E, Scott A F, Kazazian HH Jr. Isolation of an active human transposable element. Science 1991;254:1805-1808.
7. Swergold GD. Identification, characterization, and cell specificity of a human LINE-1 promoter. Mol Cell Biol 1990;10:6718-6729.
8. Speek M. Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol Cell Biol 2001;21:1973-1985.
9. Cruickshanks HA, Vafadar-Isfahani N, Dunican DS, et al. Expression of a large LINE-1-driven antisense RNA is linked to epigenetic silencing of the metastasis suppressor gene TFPI-2 in cancer. Nucleic Acids Res 2013;41:6857-6869.
10. Wei W, Gilbert N, Ooi SL, et al. Human L1 retrotransposition: cis preference versus trans complementation. Mol Cell Biol 2001;21:1429-1439.
11. Kulpa DA, Moran J V. Cis-preferential LINE-1 reverse transcriptase activity in ribonucleoprotein particles. Nat Struct Mol Biol 2006;13:655-660.
12. Luan DD, Korman MH, Jakubczak JL, Eickbush TH. Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal target site: a mechanism for non-LTR retrotransposition. Cell 1993;72:595-605.
13. Morrish TA, Gilbert N, Myers JS, et al. DNA repair mediated by endonuclease-independent LINE-1 retrotransposition. Nat Genet 2002;31:159-165.
14. Ade C, Roy-Engel AM, Deininger PL. Alu elements: an intrinsic source of human genome instability. Curr Opin Virol 2013;3:639-645.
15. Babatz TD, Burns KH. Functional impact of the human mobilome. Curr Opin Genet Dev 2013;23:264-270.
16. Raiz J, Damert A, Chira S, et al. The non-autonomous retrotransposon SVA is trans-mobilized by the human LINE-1 protein machinery. Nucleic Acids Res 2012;40:1666-1683.
17. Cooke SL, Shlien A, Marshall J, et al.; ICGC Breast Cancer Group. Processed pseudogenes acquired somatically during cancer development. Nat Commun 2014;5:3644.
18. Soifer HS, Zaragoza A, Peyvan M, Behlke MA, Rossi JJ. A potential role for RNA interference in controlling the activity of the human LINE-1 retrotransposon. Nucleic Acids Res 2005;33:846-856.
19. Yang N, Kazazian HH Jr. L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nat Struct Mol Biol 2006;13:763-771.
20. Sienski G, Dönertas D, Brennecke J. Transcriptional silencing of transposons by Piwi and maelstrom and its impact on chromatin state and gene expression. Cell 2012;151:964-980.
21. De Fazio S, Bartonicek N, Di Giacomo M, et al. The endonuclease activity of Mili fuels piRNA amplification that silences LINE1 elements. Nature 2011;480: 259-263.
22. Sigurdsson MI, Smith AV, Bjornsson HT, Jonsson JJ. The distribution of a germline methylation marker suggests a regional mechanism of LINE-1 silencing by the piRNA-PIWI system. BMC Genet 2012;13:31.
23. Pezic D, Manakov SA, Sachidanandam R, Aravin AA. piRNA pathway targets active LINE1 elements to establish the repressive H3K9me3 mark in germ cells. Genes Dev 2014;28:1410-1428.
24. Liu C, Zhang X, Huang F, et al. APOBEC3G inhibits microRNA-mediated repression of translation by interfering with the interaction between Argonaute-2 and MOV10. J Biol Chem 2012;287:29373-29383.
25. Kinomoto M, Kanno T, Shimura M, et al. All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition. Nucleic Acids Res 2007;35: 2955-2964.
26. Koito A, Ikeda T. Intrinsic restriction activity by AID/APOBEC family of enzymes against the mobility of retroelements. Mob Genet Elements 2011;1:197-202.
27. Richardson SR, Narvaiza I, Planegger RA, Weitzman MD, Moran JV. APOBEC3A deaminates transiently exposed single-strand DNA during LINE-1 retrotransposition. Elife 2014;3:e02008.
28. Horn AV, Klawitter S, Held U, et al. Human LINE-1 restriction by APOBEC3C is deaminase independent and mediated by an ORF1p interaction that affects LINE reverse transcriptase activity. Nucleic Acids Res 2014;42:396-416.
29. Brouha B, Meischl C, Ostertag E, et al. Evidence consistent with human L1 retrotransposition in maternal meiosis I. Am J Hum Genet 2002;71:327-336.
30. van den Hurk JA, Meij IC, Seleme MC, et al. L1 retrotransposition can occur early in human embryonic development. Hum Mol Genet 2007;16:1587-1592.
31. Rodic N, Sharma R, Sharma R, et al. Long interspersed element-1 protein expression is a hallmark of many human cancers. Am J Pathol 2014;184: 1280-1286.
32. Ashktorab H, Daremipouran M, Goel A, et al. DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasia. Epigenetics 2014;9:503-512.
33. Gualtieri A, Andreola F, Sciamanna I, Sinibaldi-Vallebona P, Serafino A, Spadafora C. Increased expression and copy number amplification of LINE-1 and SINE B1 retrotransposable elements in murine mammary carcinoma progression. Oncotarget 2013;4:1882-1893.
34. Iwagami S, Baba Y, Watanabe M, et al. LINE-1 hypomethylation is associated with a poor prognosis among patients with curatively resected esophageal squamous cell carcinoma. Ann Surg 2013;257:449-455.
35. Lee E, Iskow R, Yang L, et al.; Cancer Genome Atlas Research Network. Landscape of somatic retrotransposition in human cancers. Science 2012;337:967-971.
36. Morse B, Rotherg PG, South VJ, Spandorfer JM, Astrin SM. Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma. Nature 1988;333:87-90.
37. Tubio JM, Li Y, Ju YS, et al.; ICGC Breast Cancer Group; ICGC Bone Cancer Group; ICGC Prostate Cancer Group. Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science 2014;345:1251343.
38. Hur K, Cejas P, Feliu J, et al. Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis. Gut 2014;63:635-646.
39. Beroukhim R, Getz G, Nghiemphu L, et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci USA 2007;104:20007-20012.
40. Chappell G, Kutanzi K, Uehara T, et al. Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice. Int J Cancer 2014;134: 2778-2788.
41. Deroo LA, Bolick SC, Xu Z, et al. Global DNA methylation and one-carbon metabolism gene polymorphisms and the risk of breast cancer in the Sister Study. Carcinogenesis 2014;35:333-338.
42. Ogino S, Nishihara R, Lochhead P, et al. Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level. J Natl Cancer Inst 2013;105:130-140.
43. Kamiyama H, Suzuki K, Maeda T, et al. DNA demethylation in normal colon tissue predicts predisposition to multiple cancers. Oncogene 2012;31: 5029-5037.
44. Shuangshoti S, Hourpai N, Pumsuk U, Mutirangura A. Line-1 hypomethylation in multistage carcinogenesis of the uterine cervix. Asian Pac J Cancer Prev 2007;8:307-309.
45. Inamura K, Yamauchi M, Nishihara R, et al. Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis. J Natl Cancer Inst 2014;106.
46. Zhu C, Utsunomiya T, Ikemoto T, et al. Hypomethylation of long interspersed nuclear element-1 (LINE-1) is associated with poor prognosis via activation of c-MET in hepatocellular carcinoma. Ann Surg Oncol 2014;21(suppl 4): S729-S735.
47. Shigaki H, Baba Y, Watanabe M, et al. LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis. Gastric Cancer 2013;16:480-487.
48. Li J, Huang Q, Zeng F, et al. The prognostic value of global DNA hypomethylation in cancer: a meta-analysis. PLoS One 2014;9:e106290.
49. Neale RE, Clark PJ, Fawcett J, et al. Association between hypermethylation of DNA repetitive elements in white blood cell DNA and pancreatic cancer. Cancer Epidemiol 2014;38:576-582.
50. Akers SN, Moysich K, Zhang W, et al. LINE1 and Alu repetitive element DNA methylation in tumors and white blood cells from epithelial ovarian cancer patients. Gynecol Oncol 2014;132:462-467.
51. Walters RJ, Williamson EJ, English DR, et al. Association between hypermethylation of DNA repetitive elements in white blood cell DNA and early-onset colorectal cancer. Epigenetics 2013;8:748-755.
52. Hoshimoto S, Kuo C T, Chong KK, et al. AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome. J Invest Dermatol 2012;132:1689-1697.
53. Ramzy II, Omran DA, Hamad O, Shaker O, Abboud A. Evaluation of serum LINE-1 hypomethylation as a prognostic marker for hepatocellular carcinoma. Arab J Gastroenterol 2011;12:139-142.
54. Wu HC, Delgado-Cruzata L, Flom JD, et al. Repetitive element DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry. Carcinogenesis 2012;33:1946-1952.
55. Tahara T, Maegawa S, Chung W, et al. Examination of whole blood DNA methylation as a potential risk marker for gastric cancer. Cancer Prev Res (Phila) 2013;6:1093-1100.
56. Gao Y, Baccarelli A, Shu XO, et al. Blood leukocyte Alu and LINE-1 methylation and gastric cancer risk in the Shanghai Women's Health Study. Br J Cancer 2012;106:585-591.
57. Kaer K, Branovets J, Hallikma A, Nigumann P, Speek M. Intronic L1 retrotransposons and nested genes cause transcriptional interference by inducing intron retention, exonization and cryptic polyadenylation. PLoS One 2011;6:e26099.
58. Wanichnopparat W, Suwanwongse K, Pin-On P, Aporntewan C, Mutirangura A. Genes associated with the cis-regulatory functions of intragenic LINE-1 elements. BMC Genomics 2013;14:205.
59. Shukla R, Upton KR, Muñoz-Lopez M, et al. Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell 2013;153: 101-111.
60. Han K, Sen SK, Wang J, et al. Genomic rearrangements by LINE-1 insertion-mediated deletion in the human and chimpanzee lineages. Nucleic Acids Res 2005;33:4040-4052.
61. Gilbert N, Lutz S, Morrish TA, Moran J V. Multiple fates of L1 retrotransposition intermediates in cultured human cells. Mol Cell Biol 2005;25: 7780-7795.
62. Xiao-Jie L, Ai-Mei G, Li-Juan J, Jiang X. Pseudogene in cancer: real functions and promising signature. J Med Genet 2015;52:17-24.
63. Moran JV, DeBerardinis RJ, Kazazian HH Jr. Exon shuffling by L1 retrotransposition. Science 1999;283:1530-1534.
64. Chow JC, Ciaudo C, Fazzari MJ, et al. LINE-1 activity in facultative heterochromatin formation during X chromosome inactivation. Cell 2010;141:956-969.
65. Bojang P Jr, Roberts RA, Anderton MJ, Ramos KS. Reprogramming of the HepG2 genome by long interspersed nuclear element-1. Mol Oncol 2013;7:812-825.
66. Spengler RM, Oakley CK, Davidson BL. Functional microRNAs and target sites are created by lineage-specific transposition. Hum Mol Genet 2014;23: 1783-1793.
67. Kapusta A, Kronenberg Z, Lynch VJ, et al. Transposable elements are major contributors to the origin, diversification, and regulation of vertebrate long noncoding RNAs. PLoS Genet 2013;9:e1003470.
68. Cheng DL, Xiang YY, Ji LJ, Lu XJ. Competing endogenous RNA interplay in cancer: mechanism, methodology, and perspectives. Tumour Biol 2015; 36:479-488.
69. Sciamanna I, Gualtieri A, Cossetti C, et al. A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines. Oncotarget 2013;4:2271-2287.
70. Lau CC, Sun T, Ching AK, et al. Viral-human chimeric transcript predisposes risk to liver cancer development and progression. Cancer Cell 2014;25:335-349.
71. Han JS, Szak S T, Boeke JD. Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes. Nature 2004;429:268-274.
72. DiFeo A, Martignetti JA, Narla G. The role of KLF6 and its splice variants in cancer therapy. Drug Resist Updat 2009;12:1-7.
73. Chen J, Weiss WA. Alternative splicing in cancer: implications for biology and therapy. Oncogene 2015;34:1-14.
74. Chen L, Dahlstrom JE, Chandra A, Board P, Rangasamy D. Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer. Breast Cancer Res Treat 2012;136:129-142.
75. Zhu Y, Feng F, Yu J, et al. L1-ORF1p, a Smad4 interaction protein, promotes proliferation of HepG2 cells and tumorigenesis in mice. DNA Cell Biol 2013;32:531-540.
76. Yang Q, Feng F, Zhang F, et al. LINE-1 ORF-1p functions as a novel HGF/ETS-1 signaling pathway co-activator and promotes the growth of MDA-MB-231 cell. Cell Signal 2013;25:2652-2660.
77. Li M Y, Zhu M, Feng F, et al. Long interspersed nucleotide acid element-1 ORF-1 protein promotes proliferation and invasion of human colorectal cancer LoVo cells through enhancing ETS-1 activity. Genet Mol Res 2014;13:6981-6994.
78. Carlini F, Ridolfi B, Molinari A, et al. The reverse transcription inhibitor abacavir shows anticancer activity in prostate cancer cell lines. PLoS One 2010;5: e14221.
79. Patnala R, Lee SH, Dahlstrom JE, et al. Inhibition of LINE-1 retrotransposon-encoded reverse transcriptase modulates the expression of cell differentiation genes in breast cancer cells. Breast Cancer Res Treat 2014;143:239-253.
80. Houédé N, Pulido M, Mourey L, et al. A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer. Oncologist 2014;19:1227-1228.
81. Wongpaiboonwattana W, Tosukhowong P, Dissayabutra T, Mutirangura A, Boonla C. Oxidative stress induces hypomethylation of LINE-1 and hypermethylation of the RUNX3 promoter in a bladder cancer cell line. Asian Pac J Cancer Prev 2013;14:3773-3778.
82. Giorgi G, Marcantonio P, Del Re B. LINE-1 retrotransposition in human neuroblastoma cells is affected by oxidative stress. Cell Tissue Res 2011;346:383-391.
83. Gasche JA, Hoffmann J, Boland CR, Goel A. Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells. Int J Cancer 2011;129:1053-1063.
84. Morikawa T, Kuchiba A, Liao X, et al. Tumor TP53 expression status, body mass index and prognosis in colorectal cancer. Int J Cancer 2012;131: 1169-1178.
85. Ohnishi S, Ma N, Thanan R, et al. DNA damage in inflammation-related carcinogenesis and cancer stem cells. Oxid Med Cell Longev 2013;2013: 387014.
86. Lonkar P, Dedon PC. Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates. Int J Cancer 2011;128:1999-2009.
87. Xu H, Yan Y, Deb S, et al. Cohesin Rad21 mediates loss of heterozygosity and is upregulated via Wnt promoting transcriptional dysregulation in gastrointestinal tumors. Cell Rep 2014;9:1781-1797.
88. Senthong A, Kitkumthorn N, Rattanatanyong P, Khemapech N, Triratanachart S, Mutirangura A. Differences in LINE-1 methylation between endometriotic ovarian cyst and endometriosis-associated ovarian cancer. Int J Gynecol Cancer 2014;24:36-42.
89. Hoadley KA, Yau C, Wolf DM, et al.; Cancer Genome Atlas Research Network. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 2014;158:929-944.